prevexxion rn
boehringer ingelheim vetmedica gmbh - live recombinant marek’s disease (md) virus, serotype 1, strain rn1250 - immunologicals for aves - kylling - for active immunisation of one-day-old chicks to prevent mortality and clinical signs and reduce lesions caused by marek’s disease (md) virus (including very virulent md virus).
prevexxion rn+hvt+ibd
boehringer ingelheim vetmedica gmbh - live recombinant marek’s disease virus, serotype 1, strain rn1250; live recombinant turkey herpesvirus, expressing the vp2 protein of infectious bursal disease virus, strain vhvt013-69 - immunologicals for aves, domestic fowl, avian herpes virus (marek's disease) + avian infectious bursal disease virus (gumboro disease) + newcastle disease virus/paramyxovirus - kylling - for active immunisation of one-day-old chicks to prevent mortality and clinical signs and reduce lesions caused by marek’s disease (md) virus (including very virulent md virus), and to prevent mortality, clinical signs and lesions caused by infectious bursal disease (ibd) virus.
rabipur 2,5 ie/dosis pulver og solvens til injektionsvæske, opløsning
gsk vaccines gmbh - rabiesvirus, stamme flury lep (inaktiveret) - pulver og solvens til injektionsvæske, opløsning - 2,5 ie/dosis
verorab 3,25 ie pulver og solvens til injektionsvæske, suspension, fyldt injektionssprøjte
sanofi pasteur - rabiesvirus stamme, wistar pm/wi 38-1503-3m (inaktiveret) - pulver og solvens til injektionsvæske, suspension, fyldt injektionssprøjte - 3,25 ie
suvaxyn csf marker
zoetis belgium sa - live recombinant e2 gene-deleted bovine viral diarrhoea virus containing classical swine fever virus e2 gene (cp7_e2alf) - live viral vaccines, immunologicals for suidae - svin - til aktiv immunisering af svin fra 7 uger gamle og fremefter for at forhindre dødelighed og reducere infektion og sygdom forårsaget af klassisk svinepestvirus (csfv). onset of immunity: 14 days after vaccinationduration of immunity: at least 6 months after vaccinationfor active immunisation of breeding females to reduce transplacental infection caused by csfv. onset of immunity: 21 days after vaccinationduration of immunity has not been demonstrated.
versican plus dhp lyofilisat og solvens til injektionsvæske, suspension
zoetis animal health aps - canint adenovirus type 2, stamme cav-2-bio 13 (levende, svækket), canint parvovirus, type 2b, stamme cpv-2b bio 12/b (levende, svækket), hundesygevirus, stamme cdv, stamme bio 11/a (levende, svækket) - lyofilisat og solvens til injektionsvæske, suspension
purevax rcp felv
boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains), attenuated feline panleucopenia virus (pli iv), felv recombinant canarypox virus (vcp97) - immunologicals for felidae, - katte - active immunisation of cats aged 8 weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs ;against feline panleucopenia to prevent mortality and clinical signs;against leukaemia to prevent persistent viraemia and clinical signs of the related disease. onsets of immunity are 1 week after primary vaccination course for rhinotracheitis, calicivirus and panleucopenia components, and 2 weeks after primary vaccination course for feline leukaemia component. the duration of immunity is one year after the last re-vaccination for the feline leukaemia component, and one year after primary vaccination course and three years after the last re-vaccination for the rhinotracheitis, calicivirosis and panleucopenia components.
purevax rc
boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains) - immunologicals for felidae, - katte - active immunisation of cats aged eight weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs. onsets of immunity isone week after primary vaccination course. the duration of immunity is one year after primary vaccination course and three years after the last re-vaccination.
versican plus dp lyofilisat og solvens til injektionsvæske, suspension
zoetis finland oy - canint parvovirus, type 2b, stamme cpv-2b bio 12/b (levende, svækket), hundesygevirus, stamme cdv, stamme bio 11/a (levende, svækket) - lyofilisat og solvens til injektionsvæske, suspension
nobivac dhppil vet. pulver og solvens til injektionsvæske, suspension
intervet international b.v. - canine hepatitisvirus type 2 (cav2), stamme manhatten lpv3 (levende, svækket), canine parainfluenzavirus (cpiv), stamme cornell (levende, svækket), canint parvovirus, stamme 154 (levende, svækket), hundesygevirus, stamme onderstepoort (levende, svækket), leptospira interrogans serogruppe canicola, stamme ca-12-000 (inaktiveret), leptospira interrogans serogruppe icterohaemorrhagiae, stamme 820k (inaktiveret) - pulver og solvens til injektionsvæske, suspension